TITLE

Low-Level Viremia and Proviral DNA Impede Immune Reconstitution in HIV-1--Infected Patients Receiving Highly Active Antiretroviral Therapy

AUTHOR(S)
Ostrowski, Sisse R.; Katzenstein, Terese L.; Thim, Per T.; Pedersen, Bente K.; Gerstoft, Jan; Ullum, Henrik
PUB. DATE
February 2005
SOURCE
Journal of Infectious Diseases;2/1/2005, Vol. 191 Issue 3, p348
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Immunological and virological consequences of low-level viremia in human immunodeficiency virus (HIV) type 1-infected patients receiving highly active antiretroviral therapy (HAART) remain to be determined. Methods. For 24 months, 101 HAART-treated, HIV-1-infected patients with HIV RNA levels ⩽200 copies/mL were followed prospectively: HIV RNA level and CD4 and CD8 cell counts were investigated every 3 months, and proviral DNA and T cell subsets were investigated every 6 months. Results. During follow-up, 33 patients had HIV RNA levels ⩽20 copies/mL at all visits (uVL patients), where-as 68 patients had HIV RNA levels >20 copies/mL at ⩾1 visit (dVL patients) (median increase, 81 copies/mL [interquartile range, 37-480 copies/mL]). dVL patients had higher concentrations of CD8 cells, activated and memory T cells, and proviral DNA, compared with uVL patients (P<.05). A higher HIV RNA level was independently associated with reduced CD4 gain (P<.001). A higher HIV RNA level also was associated with increases in activated CD8+CD38+ and CD8+HLA-DR+ cells (P< .05), and a higher level of activated CD8+CD38+ cells was independently associated with reduced CD4 gain (P < .05). A higher proviral DNA level was associated with increases in CD4+CD45RA-D28- effector cells and reductions in naive CD4+CD45RA+CD62L+ and CD8+CD45RA+CD62L+ cells (P<.05). Higher levels of activated CD4+HLA-DR+ and early differentiated CD4+CD45RA-D28+ cells predicted increased risk of subsequent detectable viremia in patients with undetectable HIV RNA (P<.05). Conclusion. These findings indicate that low-level viremia and proviral DNA are intimately associated with the immunological and virological equilibrium in patients receiving HAART.
ACCESSION #
15563584

 

Related Articles

  • Early Treatment and HIV-1 Reservoirs: A Stitch in Time? Henrich, Timothy J.; Gandhi, Rajesh T. // Journal of Infectious Diseases;Oct2013, Vol. 208 Issue 8, p1189 

    The article presents the author's comments on the implications of antiretroviral therapy (ART) during acute human immunodeficiency virus type 1 (HIV-1) infection on viral reservoirs. It specifically refers to a study which examined HIV-1 nucleic acid levels and T-cell activation in patients who...

  • Early Virologic Failure in a Pilot Study Evaluating the Efficacy of Therapy Containing Once-Daily Abacavir, Lamivudine, and Tenofovir DF in Treatment-Naive HIV-Infected Patients. Khanlou, Homayoun; Yeh, Vivian; Guyer, Bill; Farthing, Charles // AIDS Patient Care & STDs;Mar2005, Vol. 19 Issue 3, p135 

    Previous investigational data using abacavir (ABC), lamuvidine (3TC), and zidovudine has suggested the possibility of triple nucleoside analogue reverse transcriptase inhibitors (NRTI) therapy as an option in the treatment of HIV infection. We performed a pilot study to assess the potency of...

  • Three-Class Antiretroviral Resistance in a Patient with Acute HIV-1 Infection. Gentz, Mark; Levin, Todd P.; Klibanov, Olga M.; Feingold, Anat; Condoluci, David V. // AIDS Patient Care & STDs;Nov2006, Vol. 20 Issue 11, p741 

    Antiretroviral resistance in treatment-naïve patients with HIV-1 infection is on the rise in both resource-rich and resource-poor countries. We report a case of three-class primary antiretroviral resistance detected by a genotypic assay in a 19-year-old woman with acute HIV-1 infection. Her...

  • HIV-associated early gastric adenocarcinoma successfully cured with surgery, and followed over eight years. Manfredi, Roberto; Sabbatani, Sergio; Fasulo, Giovanni // International Journal of STD & AIDS;Jul2007, Vol. 18 Issue 7, p501 

    An extremely rare case report of HIV-associated gastric adenocarcinoma surgically treated in the year 1998 in a 37-year-old male patient already HIV positive for 10 years, with a complete post-surgery disease-free follow-up of eight years, is described. An international literature search allowed...

  • South Africans Win Some, Lose Some. Houlton, Sarah // Pharmaceutical Executive;Oct2003, Vol. 23 Issue 10, p24 

    Reports that the South African government has approved the provision of antiretroviral drugs to HIV-positive South Africans. Funding by the Global Fund to Fight AIDS, Malaria and Tuberculosis of an AIDS program in KwaZulu Natal.

  • Human Immunodeficiency Virus (HIV) and endodontics: a review. Bürklein, Sebastian; Schäfer, Edgar // Endodontic Practice Today;2007, Vol. 1 Issue 1, p37 

    Due to the introduction of highly active antiretroviral therapy (HAART), HIV infection has gradually become more of a chronic immunodeficiency disease. In response to HAART, the CD4 cell count, in most cases, increases and thereby the HIV-infected patients are at a lower risk of developing...

  • Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis. Price, Huw; Dunn, David; Pillay, Deenan; Bani-Sadr, Firouze; de Vries-Sluijs, Theodora; Jain, Mamta K.; Kuzushita, Noriyoshi; Mauss, Stefan; Núñez, Marina; Nüesch, Reto; Peters, Marion; Reiberger, Thomas; Stephan, Christoph; Tan, Lionel; Gilson, Richard // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    Background: Hepatitis B coinfection is common in HIV-positive individuals and as antiretroviral therapy has made death due to AIDS less common, hepatitis has become increasingly important. Several drugs are available to treat hepatitis B. The most potent and the one with the lowest risk of...

  • Body Mass Index and CD4+ T-Lymphocyte Recovery in HIV-Infected Men with Viral Suppression on Antiretroviral Therapy. Palermo, Brandon; Bosch, Ronald J.; Bennett, Kara; Jacobson, Jeffrey M. // HIV Clinical Trials;Jul/Aug2011, Vol. 12 Issue 4, p222 

    Purpose: To better characterize the relationship between body mass index (BMI) and CD4+ T-lymphocyte recovery in HIV disease.Methods: We analyzed the association between baseline BMI and CD4+ T-lymphocyte increases, as well as the association between BMI and immune activation (CD38 and HLA-DR...

  • The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Stover, J; Johnson, P; Zaba, B; Zwahlen, M; Dabis, F; Ekpini, H E // Sexually Transmitted Infections;Aug2008 Supplement 1, Vol. 84 Issue S1, pi24 

    Background: The approach to national and global estimates of HIV/AIDS used by UNAIDS starts with estimates of adult HIV prevalence prepared from surveillance data using either the Estimation and Projection Package (EPP) or the Workbook. Time trends of prevalence are transferred to Spectrum to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics